RecruitingPhase not listedNCT06297291
Global Paradise System US Post Approval Study
Sponsor: ReCor Medical, Inc.
Austin, TX · Dallas, TX · Kingwood, TX · +43 more sites
Hypertension clinical trials in Dallas, TX
19 recruiting hypertension studies with a site in Dallas, TX.
RecruitingPhase 3NCT07181109
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Sponsor: Alnylam Pharmaceuticals
Allen, TX · Amarillo, TX · +270 more sites
RecruitingPhase 3NCT06822738
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Sponsor: AbbVie
Dallas, TX · El Paso, TX · +26 more sites
RecruitingNot applicableNCT06911632
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Sponsor: Tempus AI
Dallas, TX · Houston, TX · +37 more sites
RecruitingPhase 2NCT07142356
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Sponsor: Retension Pharmaceuticals. Inc.
Bellaire, TX · Dallas, TX · Plano, TX · +31 more sites
RecruitingPhase 3NCT06742723
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Sponsor: AstraZeneca
Arlington, TX · Austin, TX · +130 more sites
RecruitingPhase 2NCT06343298
To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension
Sponsor: E-Star BioTech, LLC
Coppell, TX · Dallas, TX · Denton, TX · +20 more sites
RecruitingNot applicableNCT04553523
Hydrus® Microstent New Enrollment Post-Approval Study
Sponsor: Alcon Research
Austin, TX · Dallas, TX · El Paso, TX · +19 more sites
RecruitingEarly Phase 1NCT04838678
Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)
Sponsor: University of Texas Southwestern Medical Center
Dallas, TX
RecruitingPhase not listedNCT06388421
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Sponsor: United Therapeutics
Dallas, TX · Houston, TX · +67 more sites
RecruitingPhase not listedNCT04278404
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Sponsor: Duke University
Austin, TX · Dallas, TX · Houston, TX · +47 more sites
RecruitingPhase 1 / Phase 2NCT06143566
Polypill for Prevention of Cardiomyopathy
Sponsor: University of Texas Southwestern Medical Center
Dallas, TX
RecruitingNot applicableNCT06843577
A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects
Sponsor: Zona Health, Inc
Dallas, TX · Houston, TX · +8 more sites
RecruitingPhase 1 / Phase 2NCT06649110
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Sponsor: Novartis Pharmaceuticals
Austin, TX · Dallas, TX · +17 more sites
RecruitingNot applicableNCT07659821
Harvesting Health: Advancing Nutrition and Wellness for Moms and Babies
Sponsor: Texas A&M University
College Station, TX · Dallas, TX · Mansfield, TX
RecruitingNot applicableNCT05889650
External Lumbar Drainage to Reduce ICP in Severe TBI: a Phase 1 Clinical Trial
Sponsor: Brain Trauma Foundation
Dallas, TX · Fort Sam Houston, TX · Houston, TX · +3 more sites
RecruitingNot applicableNCT05106036
Preventing Cognitive Decline by Reducing BP Target Trial
Sponsor: University of Texas Southwestern Medical Center
Dallas, TX
Not yet recruitingPhase 2NCT07654231
Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchicine in CKD
Sponsor: University of Texas Southwestern Medical Center
Dallas, TX
Not yet recruitingPhase 2NCT07601295
Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)
Sponsor: Stanford University
Dallas, TX · +9 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.